EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR
Ukhyun Jo(Center for Cancer Research), Yeul Hong Kim(Korea University)
Cited by 58
Related Papers
Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents
|Molecular Cancer Therapeutics|2021|110
The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs
|Molecular Cancer Therapeutics|2024|23